The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Single nucleotide polymorphisms (SNPs) of the platinum pharmacogenetic and VEGF pathways: Association with survival of platinum-treated stage IV non-small cell lung cancer (NSCLC) patients.
Sinead Cuffe
No relevant relationships to disclose
Xiaoping Qiu
No relevant relationships to disclose
Abul Kalam Azad
No relevant relationships to disclose
Xin Qiu
No relevant relationships to disclose
Kevin Boyd
No relevant relationships to disclose
Qin Kuang
No relevant relationships to disclose
Sharon Marsh
No relevant relationships to disclose
Sevtap Savas
No relevant relationships to disclose
Marjan Emami
No relevant relationships to disclose
Nicole Perera
No relevant relationships to disclose
Prakruthi R. Palepu
No relevant relationships to disclose
Zhuo Chen
No relevant relationships to disclose
Devalben Patel
No relevant relationships to disclose
Dangxiao Cheng
No relevant relationships to disclose
Ronald Feld
No relevant relationships to disclose
Natasha B. Leighl
No relevant relationships to disclose
Frances A. Shepherd
No relevant relationships to disclose
Ming Sound Tsao
No relevant relationships to disclose
Wei Xu
No relevant relationships to disclose
Geoffrey Liu
No relevant relationships to disclose